Carmell Therapeutics Corporation (CTCX) — Financial Flexibility Index
Carmell Therapeutics Corporation (CTCX) has a Financial Flexibility Index of -0.11x as of March 2025. Free cash flow of $-752.95K (operating CF $-752.95K minus capex $0.00) represents 0% of total liabilities ($7.14 Million). Check Carmell Therapeutics Corporation tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Carmell Therapeutics Corporation Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Carmell Therapeutics Corporation across 4 annual periods. For the full cash flow conversion analysis, see Carmell Therapeutics Corporation (CTCX) cash flow conversion.
Annual Financial Flexibility Index for Carmell Therapeutics Corporation (2021–2024)
Year-by-year free cash flow to debt coverage for Carmell Therapeutics Corporation. Explore cash flow to debt ratio of Carmell Therapeutics Corporation to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.71x | $-4.39 Million | $-4.39 Million | $6.19 Million | ▼ -234.3% |
| 2023 | -0.21x | $-8.32 Million | $-8.35 Million | $39.20 Million | ▼ -145.2% |
| 2022 | -0.09x | $-3.42 Million | $-3.43 Million | $39.54 Million | ▼ -130.4% |
| 2021 | -0.04x | $-1.17 Million | $-1.18 Million | $31.13 Million | — |